Thoracic Fluid Content as an Outcome Predictor in Intensive Care Unit
1 other identifier
observational
130
1 country
1
Brief Summary
Hemodynamic monitoring is measuring and monitoring the factors that influence the force and flow of the blood. It is an important aspect of patients care in operating rooms and critical care units. It aims to guide medical management so as to prevent or treat organ failure and improve the outcomes of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 28, 2025
CompletedFirst Posted
Study publicly available on registry
August 3, 2025
CompletedAugust 13, 2025
August 1, 2025
6 months
July 28, 2025
August 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
length of respiratory intensive care unit stay
Thoracic fluid content as an outcome predictor in length of stay in respiratory intensive care unit
6 months
duration of invasive mechanical ventilation
Thoracic fluid content as an outcome predictor in duration of invasive mechanical ventilation
6 months
Secondary Outcomes (1)
mortality
12 months
Study Arms (1)
Patients indicated for admission to respiratory critical care unit of chest medicine department
130 patients \>18 years old were enrolled during the period from December 2023 to December 2024
Interventions
Hemodynamic parameters was measured daily at 10 a.m by using ICON non-invasive cardiometer model C3 made in Germany by OSYPKA medical (figure 5) by placing the four sensors on the neck and left side of the thorax allow for the continuous measurement of the changes of electrical conductivity within the thorax parameters such as CO, TFC, SVV and FTC were calculated 3 times with 5-min intervals and stored on the device automatically.
Eligibility Criteria
Any Patient indicated for admission to respiratory critical care unit of chest medicine department at Mansoura University Hospitals whatever the indication was
You may qualify if:
- Age \>18 years.
- Patients indicated for admission to respiratory critical care unit of chest medicine department at Mansoura University Hospitals whatever the indication was.
You may not qualify if:
- Patients with malignancy either primary or metastatic lung cancer.
- Advanced chronic pulmonary fibrosis.
- Pleural and or pericardial effusions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mohamed AbdElmoniem
Al Mansurah, 35516, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed AbdElmoniem
Lecturer of chest medicine faculty of medicine Mansoura university
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer faculty of medicine
Study Record Dates
First Submitted
July 28, 2025
First Posted
August 3, 2025
Study Start
December 1, 2023
Primary Completion
June 1, 2024
Study Completion
December 1, 2024
Last Updated
August 13, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share